Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05120648 · ClinicalTrials.gov registry record
Effects of Biofeedback on Somatic Symptoms
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 20
- Enrollment target
NCT05120648: Completed study, sponsored by University of California, Los Angeles.
NCT05120648 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05120648 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) biofeedback, respiration/relaxation training, and body temperature control to treat UCLA patients with chronic medical conditions (e.g. pulmonary, neurology) and somatic symptoms (pain, psychosomatic non-epileptic seizures, panic attacks, long-COVID symptoms). The aim of the study is to determine whether patients who complete a six-session biofeedback protocol report a decrease in somatic symptoms, and improvements in self-rated mental health (depression, anxiety, quality of life) after the program and at three-months follow-up. The investigators will also study whether these improvements are also related to reduced healthcare utilization.
Primary Outcome
Improvement in self-rated depressive sx on the PHQ-9
Interventions
- BEHAVIORAL Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-09-01 |
| Est. Completion | 2024-09-01 |
What the finished NCT05120648 record still lists
NCT05120648 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Biofeedback is the first listed.
NCT05120648 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05120648 about?
NCT05120648 is a clinical study titled "Effects of Biofeedback on Somatic Symptoms". Biofeedback is a therapeutic paradigm that teaches patients how to gain awareness and control over previously unrecognized sympathetic changes such as body temperature, blood pressure, and heart rate. We propose to use a six session biofeedback protocol that includes heart-rate variability (HRV) bio...
What is the current status of trial NCT05120648?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-09-01. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT05120648?
The interventions under investigation include: Biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05120648?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI